Product Overview
British Dragon Anastrozole Tablets carry 1 mg of anastrozole, the non-steroidal and reversible aromatase inhibitor that sits in the type II group of the class. The material is pressed and packed under GMP conditions, the active mass is printed on the pack, and the unit strength is the one used throughout the ranges below. It adds no muscle and no strength of its own. It exists to hold estrogen inside a range while something else - usually a testosterone ester or a stack built on one - produces more estradiol than the user handles comfortably.
Anastrozole attaches to the haem unit of the aromatase cytochrome P450 enzyme, which is a different target from the receptor blocking done by a SERM such as Tamoxifen Tablets. Because the enzyme itself is tied up, estradiol production falls at the source, and water held under the skin and breast tenderness usually follow it down. The binding is reversible: stop the tablets and enzyme activity returns. Two other products in the same section work the same territory - Exemestane Tablets as a steroidal irreversible alternative, and Letrobol Tablets as the more forceful agent usually held back for stubborn cases.
The practical skill with an aromatase inhibitor is restraint. Some aromatization belongs to a normal cycle and to joint comfort, libido and lipid handling; erasing it produces its own set of complaints. Most users therefore start below the label medical dose and let a blood result, not a feeling, decide the next step.
Dosage Protocol
The numbers below come from the project fact sheet and from the dosing practice recorded for this compound. The unit sold here is a 1 mg tablet, so the lower two rungs of the table mean breaking tablets.
| Beginner | 0.5 mg every other day, taken across the length of the base cycle; the lowest useful entry point and adjusted by estradiol |
| Intermediate | 1 mg every other day, with the blood result rather than the calendar guiding any change |
| Advanced | 1 mg a day or above only where aromatization is confirmed high; joint dryness and lipid changes are the cost |
| Female | No confirmed protocol for this use; the compound is documented here as a tool for estrogen control in men on cycle |
| Administration | Oral, once a day at a fixed time; the 40-50 hour half-life keeps the effect flat between doses, and tablets are split for the smaller amounts |
Suggested Protocols
An aromatase inhibitor is dosed against a stack, never on its own, so the combinations below are written as complete plans with the inhibitor at the end of the row.
What to Expect
Effects track the blood level of estradiol rather than the number of tablets swallowed, so the timeline is short and reversible.
- First one to two weeks. Estradiol falls and the estrogen-dependent water layer and breast sensitivity ease; postmenopausal women on 1 mg a day showed reductions of 85 percent or more.
- Steady state. One daily dose holds the effect level because the half-life runs past 40 hours, and no build-up period is needed.
- Past the useful range. Dry or painful joints, a flat libido and a heavier lipid picture are the signals that the enzyme has been tied up for too long.
- Limit one. The tablet changes a consequence of aromatization, not its cause; the production line keeps running underneath until the base cycle ends.
- Limit two. Long uninterrupted use in men is linked with a bone-density question, so the medicine is kept to the length of the cycle it supports.
Side Effects and Management
Almost every complaint in this list comes from taking estrogen too low rather than from the tablet itself, which makes the correction a dose decision.
Cycle Support and Follow-Up
This product is not suppressive by itself, so it does not create a recovery problem and no SERM schedule belongs to it. What does need planning is the moment the inhibitor is withdrawn from the base cycle.
